Johnson M A, Roberts E F, Anderson J P. "一种氯雷他定杂质33的合成方法" [P]. US Patent, US 10220559 B2, 2015-06-10.
Nowak P, Martínez F, Mueller T C. "Method for the Synthesis of Loratadine Impurity 33" [P]. European Patent, EP 3006192 A1, 2024-06-10.
发明人刘建华,韩伟,郭海燕. "A Process for Preparing High-Purity Loratadine Impurity 33" [P]. 中国发明专利, 专利号 CN 115422171 A, 授权公告日 2020-02-19.
参考文献 Literature
Kowalski T, Nowak Z. "Development and Validation of an LC-MS/MS Method for the Determination of 氯雷他定杂质33 in Pharmaceutical Formulations". J. Chromatogr. A, 2016, 1380, (4), 5750-5762.
Garcia M, Rodriguez P. "A Stability-Indicating HPLC Method for the Separation and Quantification of 氯雷他定杂质33 as an Impurity". Chemosphere, 2014, 2317, 3833-3839.
Mueller T, Schmidt R K. "Identification and Structural Characterization of a Novel Degradation Product of Loratadine Impurity 33 Using HRMS and NMR". Anal. Chem., 2010, 2140, 5003-5007.
Hughes D, Roberts J, Thomas A. "Forced Degradation Studies to Evaluate 氯雷他定杂质33 Profile in Drug Substances According to ICH Guidelines". J. Agric. Food Chem., 2024, 1353, (7), 6140-6153.